Relief Therapeutics Holding AG (RLFTF)

[Bill B]

Any idea on their timeline for getting the EUA?

FTA

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab [url]for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients[/url(12 years of age and older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progression to severe COVID-19, including hospitalization or death